BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9517278)

  • 41. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
    Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
    Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
    Reinfrank J; Eckardt A; Hahn KJ
    Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of verapamil on the functional state of the liver in ischemic heart disease].
    Zharov EI; Makeeva LG; Svetova SD; Makarovskiĭ VV; Shafranskiĭ IuA; Vertkina NV
    Sov Med; 1991; (12):10-3. PubMed ID: 1780769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
    Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amlodipine associated hyperpigmentation.
    Erbagci Z
    Saudi Med J; 2004 Jan; 25(1):103-5. PubMed ID: 14758392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parkinsonian syndrome and calcium channel blockers.
    Prescrire Int; 2003 Apr; 12(64):62. PubMed ID: 12674122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urinary difficulty caused by verapamil].
    Espina Ordeix J; Molina Gallardo S; Casellas Criballés E; Deniel Rosanas J
    Aten Primaria; 1997 Sep; 20(4):218. PubMed ID: 9410152
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemical injury of the oral mucosa from verapamil.
    Guttenberg SA
    N Engl J Med; 1990 Aug; 323(9):615. PubMed ID: 2381453
    [No Abstract]   [Full Text] [Related]  

  • 49. Verapamil intoxication after substitution of immediate-release for extended-release verapamil.
    Laberge P; Martineau P; Sebajang H; Lalonde G
    Am J Health Syst Pharm; 2001 Mar; 58(5):402-5. PubMed ID: 11258176
    [No Abstract]   [Full Text] [Related]  

  • 50. [Massive delayed-action verapamil poisoning].
    Hagège A; Masquet C; Beaufils P; Slama R
    Arch Mal Coeur Vaiss; 1990 Oct; 83(11):1745-7. PubMed ID: 2122853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Securon SR: sustained-release verapamil.
    Drug Ther Bull; 1987 Jun; 25(12):47-8. PubMed ID: 3608822
    [No Abstract]   [Full Text] [Related]  

  • 52. [Poisoning by delayed-release verapamil in an uremic patient].
    Robles NR; García Díaz MC; Fernández Mora G; Sánchez Casado E
    Med Clin (Barc); 1992 Dec; 99(19):741-2. PubMed ID: 1460941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Refractory cardiogenic shock and complete heart block after verapamil SR and metoprolol treatment. A case report.
    Lee DW; Cohan B
    Angiology; 1995 Jun; 46(6):517-9. PubMed ID: 7785794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of a slow-release formulation of verapamil.
    Taylor SH
    Br J Clin Pract Suppl; 1985 Jun; 42():34. PubMed ID: 3929826
    [No Abstract]   [Full Text] [Related]  

  • 55. Bradycardia in a Man With Hypertension.
    Drutel RO; Payne JR; Glancy DL
    Am J Cardiol; 2019 Oct; 124(8):1316. PubMed ID: 31443901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fatal poisoning by the retard form of verapamil. Therapeutic considerations].
    Mayer U; Buhl N; Sachs H; Sigel H
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1293-6. PubMed ID: 4028979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Slow-release verapamil poisoning].
    Rodríguez V; Barriales V; Moris C; Barriales R
    An Med Interna; 1997 Mar; 14(3):159. PubMed ID: 9235094
    [No Abstract]   [Full Text] [Related]  

  • 58. [The massive ingestion of verapamil with suicidal intent].
    Barriales Villa R; Rodríguez Blanco VM; Batalla Celorio A; Barriales Alvarez V
    An Med Interna; 1997 Oct; 14(10):542-3. PubMed ID: 9424154
    [No Abstract]   [Full Text] [Related]  

  • 59. Calcium antagonists in the management of systemic hypertension: the impact of sustained-release drug-delivery systems.
    Frishman WH; Rosenberg A; Katz B
    Coron Artery Dis; 1994 Jan; 5(1):4-13. PubMed ID: 8136931
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
    Cedro K; Dłuzniewski M; Szpytma M
    Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.